Vaxil Bio Ltd Capital Reinvestment Ratio

Latest as of March 2013: 0.02x

Vaxil Bio Ltd capital reinvestment ratio. Vaxil Bio Ltd (VXL) has a Capital Reinvestment Ratio of 0.02x as of March 2013, meaning it reinvests 0% of its operating cash flow (CA$658.00) in capital expenditures (CA$14.49). Check how aggressively does Vaxil Bio Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.02x

Capex / Operating Cash Flow

Operating Cash Flow

CA$658.00

CAD

Capital Expenditures

CA$14.49

CAD

Data as of

Mar 2013

Most recent filing

Vaxil Bio Ltd Capital Reinvestment Ratio by Year (None–None)

Vaxil Bio Ltd capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see VXL cash generation efficiency.

Year	Reinvestment Ratio	Operating CF (CAD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow